Home » Topics » BioWorld Science

BioWorld Science
RSS

Clinical trial demonstrates efficacy of NPS-R-568 in hyperparathyroidism

Nov. 24, 1997

Cantab: Q3 1997 highlights

Nov. 24, 1997

Myriad Genetics and Bayer join forces to develop dementia and depression therapies

Nov. 24, 1997

Olpadronate associated with improvement in osteogenesis imperfecta

Nov. 24, 1997

EntreMed: Q3 1997 highlights

Nov. 24, 1997

Accolate now available in Canada

Nov. 21, 1997

Floxin recommended for FDA approval

Nov. 21, 1997

Allergan files registration statement for new company

Nov. 21, 1997

RIGScan EMEA review delayed

Nov. 21, 1997

Amylin, SIDDCO join forces for metabolic drug discovery

Nov. 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.